A new study explores how 'essentially placebo' treatments raise questions about the transparency and trust that underpin the doctor-patient relationship.
‘We’re entering a new era,’ said Dr. Maximilian Konig, a rheumatologist at Johns Hopkins University who’s studying some of the possible new treatments. They offer ‘the chance to control disease in a way we’ve never seen before.’
Switzerland-based Novartis released results of what it called a next-generation treatment. A study of its experimental drug in 12 African countries found it works well against the mosquito-borne parasite that causes malaria and seems to block spread.
A recent study integrated pharmacovigilance data with nationwide health claims to reveal four drugs with the greatest elevated risk of maculopathy, potentially leading to visual impairment.
Researchers behind the study published in the New England Journal of Medicine say the discovery could potentially alter the clinical care of millions of people around the world.
